Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study
Blood Adv
.
2023 Nov 28;7(22):6839-6843.
doi: 10.1182/bloodadvances.2023011288.
Authors
Kaitlin Annunzio
1
,
Natalie S Grover
2
,
Rina Li Welkie
1
,
Pallawi Torka
3
,
Marcus P Watkins
4
,
Andrea Anampa-Guzmán
3
,
Montreh Tavakkoli
5
,
Timothy S Oh
6
,
Heather Reves
7
,
Daniel Jones
8
,
Walter Hanel
1
,
Beth Christian
1
,
Praveen Ramakrishnan Geethakumari
7
,
Reem Karmali
6
,
Stefan K Barta
5
,
Nancy L Bartlett
4
,
Adam J Olszewski
9
,
Narendranath Epperla
1
Affiliations
1
Division of Hematology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
2
Department of Medicine, Lineberger Comprehensive Cancer Center, The University of North Carolina, Chapel Hill, NC.
3
Division of Hematology and Oncology, Roswell Park Cancer Institute, Buffalo, NY.
4
Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
5
Department of Medicine, University of Pennsylvania, Philadelphia, PA.
6
Department of Medicine, Northwestern University, Chicago, IL.
7
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX.
8
Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
9
Department of Medicine, Brown University, Providence, RI.
PMID:
37792806
PMCID:
PMC10679805
DOI:
10.1182/bloodadvances.2023011288
No abstract available
Publication types
Multicenter Study
MeSH terms
Cohort Studies
Humans
Lymphocytes
Lymphoma, B-Cell, Marginal Zone* / diagnosis
Lymphoma, B-Cell, Marginal Zone* / pathology